MEDBOT-B Receives HKEX Approval for Full Circulation of H Shares
Deep News
Feb 16
MEDBOT-B (02252) has announced that the company received approval from the Hong Kong Stock Exchange dated February 13, 2026, for the listing and trading of 5.9898 million H shares (converted H shares), which is the total number of non-listed shares to be converted and listed. The conversion and listing will involve a total of 5.9898 million non-listed shares held by two of the company's shareholders (participating shareholders), accounting for approximately 0.5808% of the company's total issued shares as of the date of this announcement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.